A comparison of AAV-vector production methods for gene therapy and preclinical assessment

A comparison of AAV-vector production methods for gene therapy and preclinical assessment

Abstract Adeno Associated Virus (AAV)-mediated gene expression in the brain is widely applied in the preclinical setting to investigate the therapeutic potential of specific molecular targets, characterize various cellular functions, and model central nervous system (CNS) diseases. In therapeutic ap...

Full description

Bibliographic Details
Main Authors:	Marcus Davidsson, Matilde Negrini, Swantje Hauser, Alexander Svanbergsson, Marcus Lockowandt, Giuseppe Tomasello, Fredric P. Manfredsson, Andreas Heuer
Format:	Article
Language:	English
Published:	Nature Publishing Group 2020-12-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-020-78521-w

Similar Items

Small scale adeno-associated virus-vector production for preclinical gene delivery based on chloroform precipitation
by: Marcus Davidsson, et al.
Published: (2022-01-01)

Preclinical Assessment of Immune Responses to AAV (adeno-associated virus) Vectors
by: Etiena eBasner-Tschakarjan, et al.
Published: (2014-02-01)

AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.
by: Vidyullatha Vasireddy, et al.
Published: (2013-01-01)

Correction: AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models.
by: Vidyullatha Vasireddy, et al.
Published: (2015-01-01)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
by: Hildegund C. J. Ertl
Published: (2021-04-01)

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
by: Fanny Collaud, et al.
Published: (2019-03-01)

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
by: Anna Marei Eichhoff, et al.
Published: (2019-12-01)

Evaluation of AAV-DJ vector for retinal gene therapy
by: Yusaku Katada, et al.
Published: (2019-01-01)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
by: Jérôme Denard, et al.
Published: (2018-09-01)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
by: Wing Sum Chu, et al.
Published: (2021-04-01)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
by: Qizhao Wang, et al.
Published: (2017-03-01)

AAV Vectored Immunoprophylaxis for Filovirus Infections
by: Amira D. Rghei, et al.
Published: (2020-11-01)

Innate immune responses to AAV vectors
by: Geoffrey L Rogers, et al.
Published: (2011-09-01)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
by: Giuseppe Ronzitti, et al.
Published: (2020-04-01)

Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
by: Alejandro Orlowski, et al.
Published: (2020-03-01)

Production of AAV vectors for gene therapy : a cost-effectiveness and risk assessment
by: Rodríguez Pinhao Miessner, Diego
Published: (2016)

Bioverteilungsstudie rekombinanter AAV-Vektoren in der Maus
by: Aicher, Marcus
Published: (2007)

Thermostability of Adeno-Associated Virus (AAV) Vectors
by: Pacouret, Simon
Published: (2018)

AAV vector-mediated in vivo reprogramming into pluripotency
by: Elena Senís, et al.
Published: (2018-07-01)

AAV VECTORS VACCINES AGAINST INFECTIOUS DISEASES
by: Karen eNieto, et al.
Published: (2014-01-01)

The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors
by: Mark A. Silveria, et al.
Published: (2020-11-01)

Optimized pharmacological control over the AAV-Gene-Switch vector for regulable gene therapy
by: Shi Cheng, et al.
Published: (2021-12-01)

Novel gene therapy strategies for ADA deficiency using AAV vectors or gene editing
by: Calero, M.
Published: (2017)

Emerging Issues in AAV-Mediated In Vivo Gene Therapy
by: Pasqualina Colella, et al.
Published: (2018-03-01)

AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2: Preclinical Data on Therapeutic Time Window and Long-Term Effects
by: Regine Mühlfriedel, et al.
Published: (2017-05-01)

Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.
by: Caroline J Aalbers, et al.
Published: (2015-01-01)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
by: Hildegard Büning, et al.
Published: (2019-03-01)

Accurate Quantification of AAV Vector Genomes by Quantitative PCR
by: Cristina Martinez-Fernandez de la Camara, et al.
Published: (2021-04-01)

Optimization of AAV vectors to target persistent viral reservoirs
by: Rossana Colón-Thillet, et al.
Published: (2021-04-01)

Immune responses to AAV vectors, from bench to bedside
Published: (2015)

Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
by: Thomas Weber, et al.
Published: (2021-03-01)

Current strides in AAV-derived vectors and SIN channels further relieves the limitations of gene therapy
by: A.S. Odiba, et al.
Published: (2018-04-01)

Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia
by: Lili Wang, et al.
Published: (2021-09-01)

Receptor-targeted viral vectors: Tracking of stem cells and side by side comparison of AAV and lentiviral vectors
by: Kays, Sarah-Katharina
Published: (2015)

Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
by: Nicholas M. Kanaan, et al.
Published: (2017-09-01)

Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons.
by: Patrick Aldrin-Kirk, et al.
Published: (2014-01-01)

Rapamycin immune tolerization enables gene transfer following subcutaneous delivery of AAV6 but not CD4-retargeted AAV6 vectors in AAV-seropositive rhesus macaques
by: K. Jerome, et al.
Published: (2019-07-01)

Development of a new method using pseudorabies virus carrying AAV Rep and Cap genes for production of AAV vector
by: Pu-Sin Liu, et al.
Published: (2002)

Recombinant AAV Gene Therapy and Delivery
by: Carty, Nikisha Christine
Published: (2009)

Role of Essential Metal Ions in AAV Vector-Mediated Transduction
by: Himanshu K. Rambhai, et al.
Published: (2020-09-01)